WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report) was the recipient of a large decrease in short interest in the month of August. As of August 31st, there was short interest totaling 1,742 shares, a decrease of 33.0% from the August 15th total of 2,601 shares. Based on an average daily volume of 4,610 shares, the short-interest ratio is currently 0.4 days. Approximately 0.0% of the shares of the company are sold short.
WuXi AppTec Trading Down 0.1%
OTCMKTS WUXAY opened at $25.35 on Thursday. The stock has a 50 day moving average price of $23.31 and a 200-day moving average price of $18.64. WuXi AppTec has a one year low of $12.45 and a one year high of $27.00.
Wall Street Analysts Forecast Growth
Separately, Zacks Research raised shares of WuXi AppTec from a “hold” rating to a “strong-buy” rating in a report on Friday, August 7th. One investment analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Strong Buy”.
WuXi AppTec Company Profile
WuXi AppTec is a global pharmaceutical and biotechnology services company that provides research, development, and manufacturing support to pharmaceutical, biotechnology, and medical device companies. Its integrated platform is designed to help customers discover, develop, test, and manufacture medicines and healthcare products.
The company’s services include small-molecule drug discovery and development, laboratory testing, clinical research support, and pharmaceutical manufacturing. WuXi AppTec also provides capabilities in biologics, cell and gene therapies, medical devices, and other advanced therapeutic areas, serving customers across multiple stages of the product-development process.
Founded in 2000, WuXi AppTec is headquartered in Shanghai, China, and operates through a global network of research, testing, and manufacturing facilities in China, the United States, Europe, and other international markets.
See Also
- Five stocks we like better than WuXi AppTec
- Banc of California Bets on Short-Term Pain
- Enterprise AI to Boost Broadcom’s Software Business? What Industry Data Shows
- IonQ and NVIDIA Just Cracked a Major Quantum Computing Bottleneck
- This Gold ETF Turns a Non-Yielding Asset Into Monthly Income—But There’s a Catch
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
